AAPL News/Earnings Headlines Exciting Day

Apple, Inc. AAPL – Options Update

Yesterday morning, AAPL was among our fresh options ideas in our premarket report, as AAPL has a tendency to run into earnings, and was slated for a post-market release. That indeed was the case, and our targets, the  AAPL Weekly $375-377.50 Calls fared reasonably well.

That being said, the party is just getting started, because not only did AAPL blow Q3 earnings expectations out of the water. but the company also announced a 4-for-1 forward split planned for August. Here are the intraday gains made by our targets yesterday, which will be significantly higher once trading commences today:

AAPL Weekly $375-377.50 Calls
$375:
 10.19-15.11 (+48%)
$377.50: 8.80-13.50 (+53%)

AAPL will open at fresh all time highs, and send those contracts soaring. We’re also going to add a few other possible targets to take advantage of the current activity, with the AAPL Weekly $407.50-412.50 Calls* as well as the 08/07 $415 Calls.


More Options Review

We also had ranges of ideas in several other options chains yesterday morning and saw some truly explosive gains. Here are the ranges and total multibag profit opportunities that they provided:

QCOM Weekly $102-104 Calls
$102: 1.05-5.66 (+439%)
$103: .96-4.94 (+415%)
$104: .35-4.00 (+1043%)
_____

PYPL Weekly $190-195 Calls
$190: 2.15-5.15 (+140%)
$192.50: 1.12-3.31 (+196%)
$195: .70-1.96 (+180%)
_____

OSTK Weekly $70-75 Calls
$70:
 1.24-9.50 (+666%)
$75: .60-5.90 (+883%)

The markets in general have a tendency to run when AAPL crushes on earnings, and that could be ready to happen today, leading to added gains in one or more of these plays.
_____

More Fresh Ideas:
SPY Weekly $324-327 Calls*
FB Weekly $245-250 Calls*

*Please don’t attempt to trade options with a weekly expiration on a Friday unless you are an advanced level trader with access to disposable funds.


Extended Watchlist:
ECOR, SONN, BSGM

KNOS News with Walmart

Kronos Advanced Technologies, Inc. KNOS – Update

We have been tracking KNOS for several months now, and the stock has really provided us with some nice swings, as we most recently mentioned on . It is among our most exciting OTC plays of 2020 so far, and the party just keeps rolling along. Following an incredible 2000+% run that spanned from our April 20 alert on the stock catching a low of .011, all the way to KNOS’s .24 high a couple of weeks ago, we did see a bit of consolidation.

The stock came down to a low of .123 on the 17th and has been steadily climbing ever since, reaching .22 on Friday. That’s an added upswing of 79% and we will be on the lookout for the stock to test and potentially break past its previous high .24, especially in the light of the following new report out this morning linking the company to Walmart.

Los Angeles, CA, July 24, 2020 (GLOBE NEWSWIRE) — Los Angeles, CA, July 24, 2020 (GLOBE NEWSWIRE) — KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), a revenue-generating, product development and production company that has significantly changed the way air is moved, filtered, and sterilized, today announced that it has been approved by the retail giant, Walmart Inc. (“Walmart”) as an online supplier at Walmart.com. The Company’s air purifiers and other unique products will be available on Walmart.com very soon. (>>View Full PR)


BioSig Technologies, Inc. BSGM

We’ve also got an update on BSGM, another stock we have been tracking since the spring that has made some really nice moves for us as well. The company is preparing to present on today’s LD Micro’s “Zooming with LD” event, so we wanted to give readers a heads up on that.

Kenneth L. Londoner, Chairman and CEO of BioSig Technologies, Inc. will be presenting an overview of the Company as well as recent developments and key highlights, including progress with PURE EP(tm) system installations, the implementation of a stockholders rights plan, BioSig’s subsidiary ViralClear Pharmaceuticals, Inc.’s (ViralClear) creation of a Scientific Advisory Board and enrollment of its Phase II clinical study of merimepodib in combination with remdesivir in adult patients with advanced COVID-19.

The BioSig presentation will take place virtually over Zoom on Monday, July 27th. Mr. Londoner will also be available for one-on-one meetings with investors on the same day.

To register for this 8 am PST presentation, click here. (>>View Full PR)


Special Note: 

Investors seeking safe haven from a US Dollar faced with expected decline, and increased consumer demand from China and India are currently driving gold to record highs, with Friday bringing the highest weekly closing price on record. We have got a special gold play that we’ll be delivering to your inboxes tomorrow morning so do not miss out!


Fresh Options Ideas: 
SAP 08/21 $160-170 Calls 


Extended Watchlist:
SBFM, BBRW, HDVY, EGOC, DKMR

IBIO Streaks to New Highs

iBio, Inc. IBIO

We have been tracking IBIO since the early stages of the coronavirus pandemic, and it is among those stocks that have continued to perform and work its way to new highs.

We first highlighted it on March 17th, while it was trading a low of .76, and we followed up a couple of weeks ago at the end of June to mention that it had made a multibag move for us to 2.69 (+254%). Yesterday, with the largest single session gain of the year for IBIO, we saw a new high of 3.98. That extends our overall observed upswing on this play to 424%

Those who may have only caught our June 29th update, still had a big opportunity, as the stock pulled back to 1.85 before launching into this latest run. Gains of up to 115% were possible there.


Fresh Options Ideas
AA Weekly $12.50-13 Calls
SPCE Weekly $18-19 Calls
BSGM Weekly $7.50 Calls 


Extended Watchlist:
TH, SPOM, ITIX, PBR, VYON